Orally active thrombin inhibitors.: Part 2:: Optimization of the P2-moiety

被引:27
作者
Lange, UEW [1 ]
Baucke, D
Hornberger, W
Mack, H
Seitz, W
Höffken, HW
机构
[1] Abbott GmbH & Co KG, D-67061 Ludwigshafen, Germany
[2] BASF AG, D-67056 Ludwigshafen, Germany
关键词
thrombin inhibitor; anticoagulant; factor IIa inhibitor; serine protease inhibitor; amidine;
D O I
10.1016/j.bmcl.2006.01.046
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Synthesis and SAR of orally active thrombin inhibitors of the D-Phe-Pro-Arg type with focus on the P2-moiety are described. The unexpected increase in in vitro potency, oral bioavailability, and in vivo activity of inhibitors with dehydroproline as P2-isostere is discussed. Over a period of 24 h the antithrombin activity of the most active inhibitors with IC(50)s in the nanomolar range was determined in dogs demonstrating high thrombin inhibitory activity in plasma and an appropriate duration of action after oral administration. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2648 / 2653
页数:6
相关论文
共 40 条
[1]  
ASTRA AB, 1994, Patent No. 9429336
[2]  
BAJUSZ S, 1983, PEPTIDES 1982, P643
[3]  
BAUCKE D, UNPUB
[4]  
BAUCKE D, 1999, Patent No. 9937668
[5]  
BAUCKE D, 1998, Patent No. 9806741
[6]   Technical scale synthesis of a new and highly potent thrombin inhibitor [J].
Bernard, H ;
Bülow, G ;
Lange, UEW ;
Mack, H ;
Pfeiffer, T ;
Schäfer, B ;
Seitz, W ;
Zierke, T .
SYNTHESIS-STUTTGART, 2004, (14) :2367-2375
[7]  
BOHM HJ, 1995, Patent No. 9535309
[8]  
BOHM HJ, 1996, Patent No. 9625426
[9]   Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460):: Coapplication of structure-based design and rapid multiple analogue synthesis on solid support [J].
Brady, SF ;
Stauffer, KJ ;
Lumma, WC ;
Smith, GM ;
Ramjit, HG ;
Lewis, SD ;
Lucas, BJ ;
Gardell, SJ ;
Lyle, EA ;
Appleby, SD ;
Cook, JJ ;
Holahan, MA ;
Stranieri, MT ;
Lynch, JJ ;
Lin, JH ;
Chen, IW ;
Vastag, K ;
Naylor-Olsen, AM ;
Vacca, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :401-406
[10]   APPLICATION OF HEXAFLUOROACETONE AS PROTECTING AND ACTIVATING REAGENT IN AMINO-ACID AND PEPTIDE .14. SYNTHESIS OF (2S)-4,4-DIFLUOROPROLINE, (2S,4R)-4-FLUOROPROLINE AND THEIR DERIVATIVES FROM (S)-ASPARTIC ACID [J].
BURGER, K ;
RUDOLPH, M ;
FEHN, S ;
SEWALD, N .
JOURNAL OF FLUORINE CHEMISTRY, 1994, 66 (01) :87-90